Name | Value |
---|---|
Revenues | 52.5M |
Cost of Revenue | 18.2M |
Gross Profit | 34.3M |
Operating Expense | 13.8M |
Operating I/L | 21.4M |
Other Income/Expense | -0.8M |
Interest Income | 0.2M |
Pretax | 20.6M |
Income Tax Expense | 13.3M |
Net Income/Loss | 7.3M |
Surmodics, Inc. provides surface modification technologies for intravascular medical devices and chemical components for in vitro diagnostic immunoassay tests and microarrays. The company operates in two segments: Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment offers surface modification coating technologies to enhance medical device performance and drug-delivery coating technologies for site-specific drug delivery. The IVD segment designs and manufactures component products for diagnostic immunoassay and molecular test applications, including protein stabilization reagents, substrates, surface coatings, and antigens.